Ca 125 tumor antigen function and uses thereof
AssigneeUniversite de Sherbrooke
InventorsClaudine Rancourt, Alain Piche, Julie Beaudin
Life of this patent
Estimating the term…
Abstract
The present invention is directed to modulators of CA 125 tumor antigen, a recombinant nucleic acids, vectors, host cells, pharmaceutical compositions, uses of the foregeoing for negatively modulating CA 125 tumor antigen in mammalian cell, preventing and treating a CA 125 tumor antigen associated disease in a mammal, as well as methods of prevention and treatment of such diseases and methods of negatively regulating CA 125 tumor antigen in a mammalian cell.
Claims16
A modulator capable of negatively modulating a CA 125 tumor antigen in a mammalian cell.
A recombinant nucleic acid comprising at least one sequence selected from the group consisting of SEQ ID NOS 1 to 6.
A vector comprising a recombinant nucleic acid according to claim 10.
Dependencies are inferred from the claim text.